Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › ELV

GLENVIEW CAPITAL MANAGEMENT, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 66,599 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$25.8M, representing 0.49% of its reported portfolio and ranking #35 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed ELV holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)66.60K sh
Reported value held$25.76M
Portfolio Weight0.49%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GLENVIEW CAPITAL MANAGEMENT, LLC's ELV position evolved

GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in ELV in Q3 2023 at 14,927 shares (US$6.5M). The position peaked in Q1 2024 at 174,229 shares, worth US$90.3M. Across 5 filings, GLENVIEW CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 66,599 shares valued at US$25.8M. Notable position changes include a 154% increase in Q4 2023 (shares rose 10% over the following quarter), a 360% increase in Q1 2024 (shares rose 5% over the following quarter), a 43% trim in Q2 2024 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.93K $6.50M New
Q4 2023 37.91K $17.88M Add
Q1 2024 174.23K $90.34M Add
Q2 2024 98.58K $53.42M Reduce
Q2 2026 66.60K $25.76M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has GLENVIEW CAPITAL MANAGEMENT, LLC held ELV?

GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed ELV holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in ELV?

As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 66.60K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $25.76M, representing 0.49% of its reported portfolio and ranking #35.

Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling ELV?

In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC newly opened its position in ELV. The position peaked in Q1 2024 at 174.23K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.